MEDS
Price
$6.17
Change
+$0.12 (+1.98%)
Updated
May 2, 6:59 PM EST
SSY
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
May 1, 2:55 PM EST
8 days until earnings call
Ad is loading...

Compare trend and price MEDS vs SSY

Header iconMEDS vs SSY Comparison
Open Charts MEDS vs SSYBanner chart's image
TRxADE HEALTH
Price$6.17
Change+$0.12 (+1.98%)
Volume$2.9K
CapitalizationN/A
SunLink Health Systems
Price$0.61
Change-$0.00 (-0.00%)
Volume$2.9K
CapitalizationN/A
View a ticker or compare two or three
MEDS vs SSY Comparison Chart

Loading...

MEDSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MEDS vs. SSY commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDS is a Hold and SSY is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (MEDS: $5.97 vs. SSY: $0.61)
Brand notoriety: MEDS and SSY are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: MEDS: 1% vs. SSY: 45%
Market capitalization -- MEDS: $12.34M vs. SSY: $5.14M
MEDS [@Drugstore Chains] is valued at $12.34M. SSY’s [@Drugstore Chains] market capitalization is $5.14M. The market cap for tickers in the [@Drugstore Chains] industry ranges from $18.71B to $0. The average market capitalization across the [@Drugstore Chains] industry is $3.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEDS’s FA Score shows that 0 FA rating(s) are green whileSSY’s FA Score has 0 green FA rating(s).

  • MEDS’s FA Score: 0 green, 5 red.
  • SSY’s FA Score: 0 green, 5 red.
According to our system of comparison, both MEDS and SSY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEDS’s TA Score shows that 2 TA indicator(s) are bullish.

  • MEDS’s TA Score: 2 bullish, 4 bearish.

Price Growth

MEDS (@Drugstore Chains) experienced а -7.36% price change this week, while SSY (@Drugstore Chains) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +4.98%. For the same industry, the average monthly price growth was -9.59%, and the average quarterly price growth was -3.45%.

Reported Earning Dates

MEDS is expected to report earnings on Jul 24, 2023.

SSY is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Drugstore Chains (+4.98% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MEDS with price predictions.
OPEN
A.I.dvisor published
a Summary for SSY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MEDS($12.3M) has a higher market cap than SSY($5.14M). MEDS YTD gains are higher at: 58.213 vs. SSY (-34.409). MEDS has higher annual earnings (EBITDA): -2.68M vs. SSY (-3.03M). SSY has more cash in the bank: 2.06M vs. MEDS (34K). SSY has less debt than MEDS: SSY (663K) vs MEDS (6.48M). SSY has higher revenues than MEDS: SSY (46.9M) vs MEDS (10.5M).
MEDSSSYMEDS / SSY
Capitalization12.3M5.14M239%
EBITDA-2.68M-3.03M88%
Gain YTD58.213-34.409-169%
P/E RatioN/A1.36-
Revenue10.5M46.9M22%
Total Cash34K2.06M2%
Total Debt6.48M663K978%
FUNDAMENTALS RATINGS
MEDS vs SSY: Fundamental Ratings
MEDS
SSY
OUTLOOK RATING
1..100
5182
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4086
P/E GROWTH RATING
1..100
9998
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SSY's Valuation (44) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MEDS (99) in the null industry. This means that SSY’s stock grew somewhat faster than MEDS’s over the last 12 months.

SSY's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as MEDS (100) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.

SSY's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as MEDS (98) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.

MEDS's Price Growth Rating (40) in the null industry is somewhat better than the same rating for SSY (86) in the Hospital Or Nursing Management industry. This means that MEDS’s stock grew somewhat faster than SSY’s over the last 12 months.

SSY's P/E Growth Rating (98) in the Hospital Or Nursing Management industry is in the same range as MEDS (99) in the null industry. This means that SSY’s stock grew similarly to MEDS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDS
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
MEDSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BANC13.910.22
+1.61%
Banc of California
EXK2.670.04
+1.52%
Endeavour Silver Corp
SAIA395.54-1.29
-0.33%
Saia
TSAT7.18-0.07
-0.97%
Telesat Corp
PRTG0.23-0.01
-5.39%
Portage Biotech

MEDS and

Correlation & Price change

A.I.dvisor tells us that MEDS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDS
1D Price
Change %
MEDS100%
+0.25%
LFMD - MEDS
22%
Poorly correlated
-2.35%
PETS - MEDS
7%
Poorly correlated
N/A
LFLY - MEDS
5%
Poorly correlated
-5.66%
SSY - MEDS
4%
Poorly correlated
+0.42%
YI - MEDS
4%
Poorly correlated
+0.96%
More

SSY and

Correlation & Price change

A.I.dvisor tells us that SSY and CJJD have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSY and CJJD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSY
1D Price
Change %
SSY100%
+0.42%
CJJD - SSY
9%
Poorly correlated
-1.50%
HITI - SSY
5%
Poorly correlated
-4.37%
BIMI - SSY
5%
Poorly correlated
-1.68%
WBA - SSY
5%
Poorly correlated
-2.20%
MEDS - SSY
3%
Poorly correlated
+0.25%
More